Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 11, n. 2, p. 63–76, 2010. DOI: 10.7175/fe.v11i2.184. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/184. Acesso em: 15 feb. 2026.